The Week Ahead In Biotech (Nov. 21-Nov. 27): Takeda, Aadi, Fennec FDA Decisions, Earnings In The Spotlight In Holiday-Shortened Week
Biotech stocks showed a lack of direction in the week ending Nov. 19 before finishing modestly higher. Stocks did not have much meaningful catalysts to react to amid the winding down of the reporting season and ahead of the holiday week.
Medical Device Maker Highlights China Risk as Chinese U.S. IPOs Resume
Key Takeaways:
Meihua International files updated prospectus highlighting China oversight risk in latest filing for its modest $57 million U.S. IPO
Hotel operator Atour makes similar updated filing for U.S. IPO plan to raise $350 million, valuing the company at more than $2 billion
By Doug Young
64 Biggest Movers From Yesterday
Gainers
ABVC BioPharma, Inc. (NASDAQ: ABVC) shares climbed 137.4% to close at $6.03 on Monday on abnormally-high volume. The stock is seeing increased interest by traders on social media. Also, the company filed a mixed shelf offering on Friday after the close.
China-U.S. IPO Pipeline Creaks Back To Life With Two New Listing Plans
Key takeaways:
Two Chinese companies, drug maker LianBio and hotel operator Autour, are moving ahead with U.S. IPOs after a three-month pause on such listings
Neither company is using the controversial VIE structure, and neither comes from the sensitive internet sector
By Doug Young
The Week Ahead In Biotech (Oct. 24-30): Eyenovia, ANI Pharma, Clearside Medical FDA Decisions, Merck, Bristol-Myers Squibb Earnings, IPOs And More
Biotech stocks posted gains for the second week running, supported by multiple catalysts that included a good start to the big pharma reporting season and broader market strength.